Press release
Soaring Growth in Extended-Release Drugs Market: Projections, Key Players, and Emerging Trends
Extended-Release Drugs Market Size
What Is The Projected Market Size Of The Global Extended-Release Drugs Market And Its Growth Rate?
The extended-release drugs market has experienced substantial growth in recent years with significant projections for upcoming years:
• The market size rose from $63.11 billion in 2024 to an estimated $70.28 billion in 2025, reflecting a CAGR of 11.4%.
• Major contributors to this growth include patient compliance improvement, chronic disease prevalence, improved efficacy, and patent protection strategies.
• The market is expected to further expand, reaching $113.05 billion in 2029 at a CAGR of 12.6%.
• This forecasted growth can be attributed to advancements in personalized medicine, patient-centric drug development, an increasing incidence of lifestyle diseases, and global access to extended-release therapies.
What Is Driving The Growth In The Extended-Release Drugs Market?
The augmenting incidence of chronic conditions is a significant factor stimulating the growth of the extended-release drug market. Diseases that persist for a year or longer, requiring consistent medical care and potentially limiting daily activities, are categorized as chronic conditions. Examples include heart disease, cancer, obesity, and diabetes. The extended-release drug delivery systems maintain a relatively steady level of medication in the body over an extended period, promoting a consistent therapeutic effect and eliminating drug level fluctuations associated with immediate-release medications. The growing incidence of chronic conditions is thus propelling the extended-release drug market's growth.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp
Who Are the Key Players Driving Extended-Release Drugs Market Growth?
The extended-release drugs market is propelled by several leading companies, including:
• Pfizer Inc.
• AbbVie Inc.
• Novartis AG
• Sanofi SA
• GlaxoSmithKline PLC
• AstraZeneca Plc
• Gilead Sciences Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
What Are The Key Trends In The Extended-Release Drugs Market?
Key trends propelling the extended-release drugs market include:
• Pharmaceutical innovation
• Advancements in drug delivery systems
• Nanotechnology advancements
• Use of 3D printing in drug formulations
• Artificial Intelligence utilization
• Environmental sustainability
What Are The Segments Of The Global Extended-Release Drugs Market?
1) By Type: Sustained Release Drug, Controlled Release Drug
2) By Mode: Over-The-Counter, Prescription
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores
Which Region Leads The Extended-Release Drugs Market?
North America led the extended-release drugs market in 2024. However, the Asia-Pacific region is forecasted to be the fastest-growing in the coming years. Other regions covered in the extended-release drugs market report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.
Pre-book the Report for a Swift Delivery:
https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report
What Is Covered In The Extended-Release Drugs Market Global Market Report?
• Market Size Analysis: Analyze the Extended-Release Drugs Market size by key regions, countries, product types, and applications.
• Market Segmentation Analysis: Identify various subsegments within the Extended-Release Drugs Market for effective categorization.
• Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
• Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
• Market Contribution: Evaluate contributions of different segments to the overall Extended-Release Drugs Market growth.
• Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
• Industry Challenges: Analyze challenges and risks affecting the Extended-Release Drugs Market.
• Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customize?id=12675&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Soaring Growth in Extended-Release Drugs Market: Projections, Key Players, and Emerging Trends here
News-ID: 3833464 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
